Sign up to save your podcasts
Or
Share Long-term Evobrutinib Safe, Effective in Relapsing MS & Managing Life With MS
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Long-term Evobrutinib Safe, Effective in Relapsing MS & Managing Life With MS
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS for up to 2.5 years.He also reads “There’s No Such Thing as Perfect”, a column by Jamie Hughes.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
https://multiplesclerosisnewstoday.com/
=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
https://multiplesclerosisnewstoday.com/forums/
View all episodes
By MS News Today
4.4
88 ratings
Multiple Sclerosis News Today’s multimedia associate, Price Wooldridge, discusses how treatment with evobrutinib appeared to safely and effectively reduced relapse rates in adults with relapsing MS for up to 2.5 years.He also reads “There’s No Such Thing as Perfect”, a column by Jamie Hughes.=================================== Are you interested in learning more about multiple sclerosis? If so, please visit:
https://multiplesclerosisnewstoday.com/
https://multiplesclerosisnewstoday.com/
=====================================To join in on conversations regarding multiple sclerosis, please visit:
https://multiplesclerosisnewstoday.com/forums/
https://multiplesclerosisnewstoday.com/forums/
More shows like MS News & Perspectives
View all
The Diary Of A CEO with Steven Bartlett
8,748 Listeners